Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.

Autor: Shirane, Yuki¹ (AUTHOR) yuki0415@hiroshima-u.ac.jp, Fujii, Yasutoshi^1,2 (AUTHOR) fujiiyasu@hiroshima-u.ac.jp, Ono, Atsushi¹ (AUTHOR) hnkhr@hiroshima-u.ac.jp, Nakahara, Hikaru¹ (AUTHOR) nelsonhayes@hiroshima-u.ac.jp, Hayes, Clair Nelson¹ (AUTHOR) ryoichim@hiroshima-u.ac.jp, Miura, Ryoichi¹ (AUTHOR) serami@hiroshima-u.ac.jp, Murakami, Serami¹ (AUTHOR) shinuchi@hiroshima-u.ac.jp, Sakamoto, Naoya³ (AUTHOR) naosakam@east.ncc.go.jp, Uchikawa, Shinsuke¹ (AUTHOR) fujino920@hiroshima-u.ac.jp, Fujino, Hatsue¹ (AUTHOR) nakahara@hiroshima-u.ac.jp, Nakahara, Takashi¹ (AUTHOR) emusuke@hiroshima-u.ac.jp, Murakami, Eisuke¹ (AUTHOR) daikimiki@hiroshima-u.ac.jp, Yamauchi, Masami² (AUTHOR), Miki, Daiki¹ (AUTHOR) kawaokatomo@hiroshima-u.ac.jp, Kawaoka, Tomokazu¹ (AUTHOR) tsuge@hiroshima-u.ac.jp, Arihiro, Koji⁴ (AUTHOR) arihiro@hiroshima-u.ac.jp, Tsuge, Masataka¹ (AUTHOR) oka4683@hiroshima-u.ac.jp, Oka, Shiro¹ (AUTHOR)

Publikováno v: Cancers. Apr2024, Vol. 16 Issue 7, p1328. 18p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs.

Autor: Hiyama, Yuichi, Fujino, Hatsue, Namba, Maiko, Fujii, Yasutoshi, Uchikawa, Shinsuke, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Kawaoka, Tomokazu, Miki, Daiki, Tsuge, Masataka, Oka, Shiro

Publikováno v: Hepatology Research; Nov2024, Vol. 54 Issue 11, p981-992, 12p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.